Clinical Research Directory
Browse clinical research sites, groups, and studies.
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
We will identify plasma proteomics biomarkers for early diagnosis of lung cancer.
Official title: Identification and Functional Verification Study in Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
3700
Start Date
2023-02-01
Completion Date
2032-10-31
Last Updated
2025-05-15
Healthy Volunteers
Yes
Conditions
Interventions
Plasma protein biomarker analysis
Plasma samples from lung cancer patients were collected at the time of their diagnosis, prior to the initiation of treatment.We will use TMT-based proteomics approaches to analyze more than 2000 proteins in plasma samples from lung cancer patients .
Plasma protein biomarker analysis
Plasma samples of control subjects were collected.
Locations (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, China, China